[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Disruptor Profile: Pear Therapeutics, Inc.

June 2019 | 11 pages | ID: D330D3DFBD4EN
GlobalData

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Disruptor Profile: Pear Therapeutics, Inc.

SUMMARY

The report provides information and insights into Pear Therapeutics, Inc.'s, including -
  • Overview of the company and its product offering
  • Detailed insight into its business model, company type and headquarter
  • Information on partnership and funding
  • Biography of top management.
SCOPE
  • Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.
REASONS TO BUY
  • Gain insights into Pears’s business operations.
  • Gain insights into funding and partnerships
  • Gain understanding about its technology focus.
Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix

COMPANIES MENTIONED

Sandoz
Novartis
EDBI Pte Ltd
Blue Water Life Science Fund LP
Bridge Builders Collaborative
5AM Venture Management LLC
Novartis AG
TrustBridge Partners
Arboretum Ventures LLC
Temasek Holdings (Private) Ltd
JAZZ Venture Partners L.P.


More Publications